|
|
Cipla Ltd. - Financial Analysis Review |
| Published Date : 28 January 2010 |
|
|
|
Pages : 17 |
|
| |
|
|
|
|
|
|
|
Cipla Ltd. - Financial Analysis Review
Summary
Cipla Ltd. (Cipla) is a pharmaceutical company. It offers various drugs and healthcare products. The company manufactures and sells various OTC products, prescription products, flavors and fragrances, pesticides, and animal products. They are offered in the form of tablets, capsules, injection, suspension, syrup, and disp tablet. Cipla exports its products to 170 countries across the globe. The company’s products are certified by various recognized regulatory authorities namely Food and Drug Administration (FDA), USA; Medicines and Healthcare products Regulatory Agency (MHRA), UK and so on. It has various manufacturing facilities and R&D centers located across India.
"Cipla Ltd. - Financial Analysis Review” is an in-depth business and financial analysis of Cipla Ltd.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Nov 11, 2009: Cipla Launches Flu Drug Oseltamivir
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
|
|
|
|
Table of Contents : |
2
List of Tables 2
List of Figures 2
Cipla Ltd. - Key Facts 3
Cipla Ltd. - Business Description 3
Cipla Ltd. - Major Products and Services 4
Cipla Ltd. - History 5
Cipla Ltd. - Key Competitors 6
Cipla Ltd. - Key Employees 6
Cipla Ltd. - Locations And Subsidiaries 7
Head Office 7
Other Locations & Subsidiaries 7
Cipla Ltd. - Financial Ratios 9
Financial Ratios - Capital Market Ratios 9
Financial Ratios - Annual Ratios 9
Financial Ratios - Interim Ratios 10
Financial Ratios - Ratio Charts 11
Recent Developments 12
Sep 07, 2009: Meda, Cipla Extend Collaboration For Azelastine, Fluticasone Combination 12
Sep 08, 2009: Cipla Form Joint Venture With established Chinese Company 12
Sep 25, 2009: OTC Drugs Hog Limelight Among Indian Consumers 12
Nov 11, 2009: Cipla Launches Flu Drug Oseltamivir 13
Appendix 14
Methodology 14
Ratio Definitions 14
About Global Markets Direct 17
Contact Us 17
Disclaimer 17
List of Tables
Cipla Ltd., Key Facts 3
Cipla Ltd., Major Products and Services 4
Cipla Ltd., History 5
Cipla Ltd., Key Employees 6
Cipla Ltd., Other Locations 7
Cipla Ltd., Subsidiaries 8
List of Figures
Cipla Ltd., Performance Chart (2005 - 2009) 1
Cipla Ltd., Ratio Charts 11
|
|
|
|
Published By : Global Markets Direct |
|
|
Related
Keywords:
Energy,
Insurance, Financial,
Company Profile,
Industry Profile,
Swot Analysis,
Apparel,
Consumer, Trade,
Information technology,
Food,
Healthcare,
Construction,
Retail,
Design,Oil
and Gas,
Solar,
Miscellaneous,
Business,
Pharmaceuticals,
Technology,
Defense,
Medical,
Travel,
Power,
Metal
|
|
|
|
